---
id: 224
title: Acute HIV Infection (AHI)
category: clinical_syndromes
subcategory: viral
tags: [HIV, acute-retroviral-syndrome, seroconversion, window-period, RNA-PCR, ART]
difficulty: medium
---

## Question

How is acute HIV infection diagnosed and managed? Use **"Flu-like Illness + Risk → HIV RNA PCR (Antigen/Antibody May Be Negative), Start ART Immediately"** framework.

## Answer

### **Definition:**

**Acute HIV Infection (AHI):**
- **First 2-4 weeks** after HIV acquisition
- **Acute retroviral syndrome (ARS)** - symptomatic illness during AHI (50-90%)

**Window Period:**
- **Time from infection to positive antibody test** (10-14 days for 4th gen Ag/Ab test)

### **Clinical Presentation:**

**Acute Retroviral Syndrome (50-90%):**
- **Flu-like illness** (2-4 weeks post-exposure)

**Most Common Symptoms:**
- **Fever** (80-90%)
- **Fatigue, malaise** (70-90%)
- **Pharyngitis** (50-70%)
- **Rash** (40-80%): Maculopapular, trunk/face, usually NOT palms/soles
- **Lymphadenopathy** (40-70%): Generalized
- **Myalgias, arthralgias** (50-70%)
- **Headache** (50%)
- **Oral/genital ulcers** (10-30%)

**Labs:**
- **↑Transaminases** (mild)
- **↓CD4 count** (transient, often <500)
- **↓Platelets** (mild thrombocytopenia)
- **Atypical lymphocytes** (on smear)

**Differential Diagnosis:**
- **EBV/CMV mononucleosis, influenza, acute HCV, secondary syphilis**

### **Diagnosis:**

**HIV Testing Algorithm:**

**4th Generation HIV Ag/Ab Assay (Screening):**
- **Detects p24 antigen + HIV-1/2 antibodies**
- **Positive ~2-3 weeks** after infection (earlier than antibody-only tests)
- **May be NEGATIVE** in very early AHI (first 10-14 days)

**If Ag/Ab Positive:**
- **HIV-1/HIV-2 differentiation assay** (antibody-based)
- **If negative/indeterminate:** HIV RNA PCR (confirms AHI)

**If Ag/Ab Negative BUT High Suspicion:**
- **HIV RNA PCR** (viral load)
- **Detects virus as early as 7-10 days** after infection
- **Confirms AHI** if RNA positive

**Key Point:** In AHI, **HIV RNA is POSITIVE** but **antibody may be NEGATIVE** → order RNA PCR if high suspicion

### **Stages of HIV Infection (Fiebig Staging):**

| **Stage** | **HIV RNA** | **p24 Antigen** | **HIV Antibody** | **Western Blot** | **Timing** |
|-----------|-------------|-----------------|------------------|------------------|------------|
| **I-II** | **+** | - | - | - | Days 7-14 |
| **III-IV** | **+** | **+** | - / Indeterminate | - / Indeterminate | Days 14-21 |
| **V-VI** | **+** | **+** | **+** | **+** | Days 21-35+ |

### **Treatment:**

**Start ART IMMEDIATELY (Do NOT Wait for Confirmatory Testing):**

**Benefits of Early ART:**
1. **Preserves immune function** (limits CD4 decline)
2. **Reduces viral reservoir** (may improve long-term outcomes)
3. **Reduces transmission** (rapidly lowers viral load)
4. **May improve post-treatment control** (in some individuals)

**ART Regimen (Standard):**

**Preferred (Integrase Inhibitor-Based):**
- **Bictegravir/TAF/FTC** (Biktarvy) 1 tab PO daily
- **Dolutegravir/abacavir/lamivudine** (Triumeq) 1 tab PO daily (if HLA-B*5701 negative)
- **Dolutegravir 50mg + tenofovir alafenamide/emtricitabine** (Descovy) daily

**Alternative (If INSTI Resistance Suspected):**
- **Darunavir/ritonavir 800/100mg** + **TDF/FTC** OR **TAF/FTC** daily

**Duration:** **Lifelong** (same as chronic HIV)

### **Monitoring:**

**Baseline Labs:**
- **HIV RNA (viral load), CD4 count**
- **HIV genotype resistance testing** (before starting ART, but do NOT delay treatment)
- **HLA-B*5701** (if considering abacavir)
- **HBV/HCV serology** (co-infection screening)
- **RPR, gonorrhea/chlamydia NAAT**
- **CBC, CMP, LFTs**

**Follow-Up:**
- **Repeat HIV RNA at 4 weeks, then q3-4 months** (goal: undetectable <50 copies/mL by 6 months)
- **CD4 count q3-6 months** (until >500 and rising)

### **Transmission Risk:**

**Highest Viral Load:**
- **AHI = HIGHEST viral load** (often >1 million copies/mL)
- **Extremely high transmission risk** (10-26× higher than chronic HIV)

**Counseling:**
- **Avoid condomless sex, needle sharing** until undetectable
- **Partner notification, PrEP for partners**

### **Opportunistic Infection Prophylaxis:**

**Typically NOT needed** in AHI (CD4 usually >200 at presentation)

**If CD4 <200:**
- **PCP prophylaxis:** TMP-SMX DS daily
- **See chronic HIV OI prophylaxis guidelines**

### **Special Situations:**

**Pregnancy:**
- **Start ART immediately** (same regimen)
- **High-risk for mother-to-child transmission** (MTCT) in AHI
- **Consider integrase inhibitor-based regimen** (preferred in pregnancy)

**Neurologic Symptoms (Aseptic Meningitis):**
- **10-20%** of AHI present with meningitis
- **CSF:** Pleocytosis (lymphocytic), ↑protein, normal glucose
- **Supportive care, start ART**

## Key Points

### **High Index of Suspicion:**
- **Flu-like illness + recent high-risk exposure** → test for HIV

### **HIV RNA PCR if High Suspicion:**
- **4th gen Ag/Ab may be negative** in early AHI
- **HIV RNA positive earliest** (7-10 days post-infection)

### **Start ART Immediately:**
- **Do NOT wait for confirmatory testing**
- **Preserves immune function, reduces reservoir, lowers transmission**

### **Highest Viral Load:**
- **AHI = highest transmission risk** (often >1 million copies/mL)
- **10-26× higher transmission** than chronic HIV

### **Integrase Inhibitor-Based Regimen:**
- **Bictegravir/TAF/FTC** (Biktarvy) 1 tab daily (preferred)

### **Clinical Pearls:**
- **Flu-like illness + risk** → HIV RNA PCR (Ag/Ab may be negative early)
- **Start ART immediately** (do NOT wait for confirmatory testing)
- **Highest viral load** in AHI (>1 million copies/mL) → extremely high transmission risk
- **Preserves immune function** (limits CD4 decline, reduces reservoir)
- **Integrase inhibitor-based regimen:** Biktarvy 1 tab daily
- **Window period:** 10-14 days for 4th gen Ag/Ab, 7-10 days for HIV RNA

## Sources

- [DHHS: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV 2024]
- [CID: Acute HIV Infection 2024]

## Media

N/A
